<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <title>ATMPs Borderline Source: Alliance for Regenerative Medicine 2019</title>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="2" align="center" rowspan="1">Advance therapy medicinal products borderlines</th>
   </tr>
   <tr>
    <th align="left" rowspan="1" colspan="1">Advantages</th>
    <th align="left" rowspan="1" colspan="1">Disadvantages</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Highly personalized therapy</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Complex manufacturing</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Direct application through infusion</td>
    <td align="left" valign="top" rowspan="1" colspan="1">High up-front cost</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Longer lasting effect</td>
    <td align="left" valign="top" rowspan="1" colspan="1">One-time treatment</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Address complex diseases</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Specific regulatory and pharmacovigilance demands</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Improving health-related quality of life</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Highly specific storage requirements: short shelf life</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Fewer hospitalizations, comorbidities and associate treatment</td>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="nt102">
   <p>ATMPs: advanced therapy medicinal products.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
